We are live on ! Find out more
LUCD icon

Lucid Diagnostics
LUCD

86 hedge funds and large institutions have $35.5M invested in Lucid Diagnostics in 2025 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 31 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

182% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 11

127% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 11

62% more capital invested

Capital invested by funds: $21.9M → $35.5M (+$13.6M)

19% more funds holding

Funds holding: 72 → 86 (+14)

8.11% more ownership

Funds ownership: 17.52% → 25.63% (+8.1%)

Holders
86
Holders Change
+14
Holders Change %
+19.44%
% of All Funds
1.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
31
Reduced
11
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TSC
Two Seas Capital
New York
+$3.28M
2
AIC
AWM Investment Company
New York
+$3.27M
3
GCM
Ghisallo Capital Management
Massachusetts
+$3.23M
4
Aberdeen Group
Aberdeen Group
United Kingdom
+$2.73M
5
MCM
Masters Capital Management
Georgia
+$1.39M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$403K
2
N
Nuveen
North Carolina
-$167K
3
GAM
Gotham Asset Management
New York
-$136K
4
Squarepoint
Squarepoint
New York
-$104K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$97.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$4.57M +$433K +396,719 +10%
MCM
2
Masters Capital Management
Georgia
$4.04M +$1.39M +1,272,000 +47%
BlackRock
3
BlackRock
New York
$3.71M +$55.7K +50,969 +1%
TSC
4
Two Seas Capital
New York
$3.03M +$3.28M +3,000,000 New
AIC
5
AWM Investment Company
New York
$3.02M +$3.27M +2,990,500 New
GCM
6
Ghisallo Capital Management
Massachusetts
$2.99M +$3.23M +2,960,066 New
Aberdeen Group
7
Aberdeen Group
United Kingdom
$2.52M +$2.73M +2,500,000 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$1.69M +$106K +96,804 +6%
Alyeska Investment Group
9
Alyeska Investment Group
Illinois
$1.4M +$704K +644,839 +87%
PCM
10
Perkins Capital Management
Minnesota
$1.14M +$1.23M +1,127,000 New
State Street
11
State Street
Massachusetts
$1.03M +$431K +394,719 +63%
LM
12
Luminus Management
Texas
$922K +$129K +117,975 +15%
Wells Fargo
13
Wells Fargo
California
$721K +$532K +487,453 +215%
Goldman Sachs
14
Goldman Sachs
New York
$566K +$275K +251,476 +81%
Northern Trust
15
Northern Trust
Illinois
$509K -$28K -25,674 -5%
SS
16
Sunbelt Securities
Texas
$388K +$328K +300,000 +357%
Lido Advisors
17
Lido Advisors
California
$387K – – –
First Manhattan
18
First Manhattan
New York
$327K – – –
Renaissance Technologies
19
Renaissance Technologies
New York
$297K +$55K +50,354 +21%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$208K +$53.5K +49,017 +31%
XF
21
XML Financial
Maryland
$181K – – –
Charles Schwab
22
Charles Schwab
California
$177K – – –
UBS Group
23
UBS Group
Switzerland
$147K +$85.7K +78,459 +117%
LPL Financial
24
LPL Financial
California
$143K +$121K +110,900 +366%
Barclays
25
Barclays
United Kingdom
$101K -$21.5K -19,726 -16%
1
2 3 4

LUCD Hedge Fund Activity: Q3 2025 in Review

86 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q3 2025, worth a combined $35.5M — up 62% from $21.9M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new LUCD positions and 11 closed out — a net gain of 14 holders — while 31 added to existing stakes and 11 trimmed.

The largest buyer was Two Seas Capital, opening a new position worth an estimated $3.28M. The largest seller was Morgan Stanley, cutting an estimated $403K.

  • 86 institutional investors held Lucid Diagnostics (LUCD) as of Q3 2025, up from 72 in Q2 2025.
  • Funds reported $35.5M of Lucid Diagnostics stock for Q3 2025, up 62% quarter-over-quarter.
  • 25 funds opened new Lucid Diagnostics positions in Q3 2025 and 11 closed out, a net change of +14 holders.
  • The largest Lucid Diagnostics buyer in Q3 2025 was Two Seas Capital, an estimated $3.28M added.
  • The largest Lucid Diagnostics seller in Q3 2025 was Morgan Stanley, an estimated $403K sold.

Based on aggregated 13F filings for Q3 2025.